FDA Adopts ICH Addendum on Multi-regional Clinical Trials

FDA Adopts ICH Addendum on Multi-regional Clinical Trials

The FDA adopted the ICH guidance aimed at supporting sponsors in the collection of data from multi-regional clinical trials (MRCTs). The guidelines in E17 General Principles for Planning and Design of Multi-Regional Clinical Trials detail seven “basic principles” to...

Pin It on Pinterest